SOADOR
CSTL icon

State of Alaska Department of Revenue’s Castle Biosciences CSTL Stock Holding History

State of Alaska Department of Revenue’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37K Hold
1,553
– – ﹤0.01% 1968
2026
Q1 		$38K Hold
1,553
– – ﹤0.01% 1958
2025
Q4 		$60K Hold
1,553
– – ﹤0.01% 1881
2025
Q3 		$35K Buy
+1,553
New +$31.5K ﹤0.01% 1855

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $9.45B AUM 27.66% 1-Year Est. Return

State of Alaska Department of Revenue's CSTL Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Castle Biosciences (CSTL) position steady in Q2 2026 at 1,553 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #1968.

State of Alaska Department of Revenue first reported a position in CSTL in Q3 2025 and has held it in 4 quarters since. The position peaked at $60K in Q4 2025. 94 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • State of Alaska Department of Revenue held 1,553 shares of Castle Biosciences worth $37K as of Q2 2026.
  • State of Alaska Department of Revenue left its Castle Biosciences share count unchanged in Q2 2026.
  • Castle Biosciences made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1968 holding.
  • State of Alaska Department of Revenue first reported a position in Castle Biosciences in Q3 2025 and has held it in 4 quarters since.
  • State of Alaska Department of Revenue's Castle Biosciences position peaked at $60K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.